Unsupervised quality assessment with generative adversarial networks for 3D OCTA microvascular imaging

基于生成对抗网络的无监督质量评估在3D OCTA微血管成像中的应用

阅读:1

Abstract

Eye movements, optical opacities, and other factors can introduce artifacts during the acquisition of optical coherence tomography angiography volumes, resulting in suboptimal imaging quality. We aim to develop an automated deep learning model to separate excellent-quality from suboptimal-quality volumes in a quantitative and objective manner. Existing works use supervised classifiers trained on 2D en face images, which 1) represent quality as rigid and discrete classes, 2) require large amounts of labeled data for every type of artifact to generalize effectively, and 3) discard valuable depth information from the original volume. We propose OCTA-GAN, an efficient 3D generative adversarial network architecture that incorporates multi-scale processing layers to assess the quality of scans by fusing fine vasculature details with larger anatomical context. The unsupervised model learns patterns associated with excellent-quality volumes and accurately determines the quality of unseen volumes. Experimental results show OCTA-GAN's discriminator distinguishes excellent-quality from suboptimal-quality volumes with an AUC of 0.92, a sensitivity of 95.7%, and a specificity of 76.6%, surpassing the baseline 3D architecture (AUC = 0.55, sensitivity = 97.8%, specificity = 12.8%). Further analysis attributes the improved performance to the synergy between the generator model and discriminator architecture, whose robust feature representations effectively capture the intricate vasculature. Comparison with state-of-the-art 2D supervised en face classifiers demonstrates OCTA-GAN's ability to generalize across diverse artifacts and provides an interpretable organization of the output scores based on severity.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。